FDA approves new weight-loss drug – Fox Business

Share this Story

Wegovy – a semaglutide 2.4 mg injection administered once a week – is specifically for chronic weight management in overweight or obese adults with “at least one weight-related comorbidity,” according to pharmaceutical company Novo Nordisk.

Author: Daniella Genovese

READ MORE